Interaction between resistin and adiponectin in the proliferation of rat vascular smooth muscle cells

Molecular and Cellular Endocrinology

Volumn 366, Issue 1, 2013, Pages 108-116

  Hirai, Hiroyuki ^a   Satoh, Hiroaki ^a   Kudoh, Akihiro ^a   Watanabe, Tsuyoshi ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Adiponectin; Cell proliferation; ERK; P21; P53; Resistin

Indexed keywords

ADIPONECTIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN C FOS; PROTEIN P53; RESISTIN; THYMIDINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL COUNT; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL STIMULATION; CELL STRAIN HEK293; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; INTRACELLULAR SIGNALING; MALE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

3T3-L1 CELLS; ADIPONECTIN; ANIMALS; BUTADIENES; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DNA; ENZYME ACTIVATION; FLAVONOIDS; HEK293 CELLS; HUMANS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NITRILES; PROTEIN BINDING; PROTEIN KINASE INHIBITORS; PROTEIN MULTIMERIZATION; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; RESISTIN; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84872489335     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.12.009     Document Type: Article

References (45)

1. Banerjee R.R., Lazar M.A. Dimerization of resistin and resistin-like molecules is determined by a single cysteine. J. Biol. Chem. 2001, 276:25970-25973.
2. Banerjee R.R., Rangwala S.M., Shapiro J.S., Rich A.S., Rhoades B., Qi Y., Wang J., Rajala M.W., Pocai A., Scherer P.E., Steppan C.M., Ahima R.S., Obici S., Rossetti L., Lazar M.A. Regulation of fasted blood glucose by resistin. Science 2004, 303:1195-1198.
3. Berg A.H., Combs T.P., Du X., Brownlee M., Scherer P.E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 2001, 7:947-953.
4. Bohlen F., Kratzsch J., Mueller M., Seidel B., Friedman-Einat M., Witzigmann H., Teupser D., Koerner A., Storck M., Thiery J. Leptin inhibits cell growth of human vascular smooth muscle cells. Vascul. Pharmacol. 2007, 46:67-71.
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
6. Calabro P., Samudio I., Willerson J.T., Yeh E.T. Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation 2004, 110:3335-3340.
7. Channon K.M., Guzik T.J. Mechanisms of superoxide production in human blood vessels: relationship to endothelial dysfunction, clinical and genetic risk factors. J. Physiol. Pharmacol. 2002, 53:515-524.
8. Cho Y., Lee S.E., Lee H.C., Hur J., Lee S., Youn S.W., Lee J., Lee H.J., Lee T.K., Park J., Hwang S.J., Kwon Y.W., Cho H.J., Oh B.H., Park Y.B., Kim H.S. Adipokine resistin is a key player to modulate monocytes, endothelial cells, and smooth muscle cells, leading to progression of atherosclerosis in rabbit carotid artery. J. Am. Coll. Cardiol. 2011, 57:99-109.
9. Condorelli G., Aycock J.K., Frati G., Napoli C. Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice. Faseb. J. 2001, 15:2162-2170.
10. Fruebis J., Tsao T.S., Javorschi S., Ebbets-Reed D., Erickson M.R., Yen F.T., Bihain B.E., Lodish H.F. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. USA 2001, 98:2005-2010.
11. Fruhbeck G. The adipose tissue as a source of vasoactive factors. Curr. Med. Chem. Cardiovasc. Hematol. Agents 2004, 2:197-208.
12. Gartel A.L., Tyner A.L. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol. Cancer. Ther. 2002, 1:639-649.
13. Haluzik M., Colombo C., Gavrilova O., Chua S., Wolf N., Chen M., Stannard B., Dietz K.R., Le Roith D., Reitman M.L. Genetic background (C57BL/6J Versus FVB/N) strongly influences the severity of diabetes and insulin resistance in ob/ob mice. Endocrinology 2004, 145:3258-3264.
14. Heilbronn L.K., Rood J., Janderova L., Albu J.B., Kelley D.E., Ravussin E., Smith S.R. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J. Clin. Endocrinol. Metab. 2004, 89:1844-1848.
15. Hotamisligil G.S., Spiegelman B.M. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994, 43:1271-1278.
16. Hotta K., Funahashi T., Bodkin N.L., Ortmeyer H.K., Arita Y., Hansen B.C., Matsuzawa Y. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001, 50:1126-1133.
17. Jamaluddin M.S., Weakley S.M., Yao Q., Chen C. Resistin: Functional roles and therapeutic considerations for cardiovascular disease. Br. J. Pharmacol. 2011.
18. Jung H.S., Park K.H., Cho Y.M., Chung S.S., Cho H.J., Cho S.Y., Kim S.J., Kim S.Y., Lee H.K., Park K.S. Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc. Res. 2006, 69:76-85.
19. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 2006, 116:1784-1792.
20. Kaplan N.M. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch. Intern. Med. 1989, 149:1514-1520.
21. Kawanami D., Maemura K., Takeda N., Harada T., Nojiri T., Imai Y., Manabe I., Utsunomiya K., Nagai R. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem. Biophys. Res. Commun. 2004, 314:415-419.
22. Lu H.L., Wang H.W., Wen Y., Zhang M.X., Lin H.H. Roles of adipocyte derived hormone adiponectin and resistin in insulin resistance of type 2 diabetes. World J. Gastroenterol. 2006, 12:1747-1751.
23. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett. 2006, 580:2917-2921.
24. Matsuzawa Y., Funahashi T., Nakamura T. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann. NY Acad. Sci. 1999, 892:146-154.
25. Motobayashi Y., Izawa-Ishizawa Y., Ishizawa K., Orino S., Yamaguchi K., Kawazoe K., Hamano S., Tsuchiya K., Tomita S., Tamaki T. Adiponectin inhibits insulin-like growth factor-1-induced cell migration by the suppression of extracellular signal-regulated kinase 1/2 activation, but not Akt in vascular smooth muscle cells. Hypertens. Res. 2009, 32:188-193.
26. Nawrocki A.R., Hofmann S.M., Teupser D., Basford J.E., Durand J.L., Jelicks L.A., Woo C.W., Kuriakose G., Factor S.M., Tanowitz H.B., Hui D.Y., Tabas I., Scherer P.E. Lack of association between adiponectin levels and atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1159-1165.
27. Ouchi N., Kihara S., Funahashi T., Matsuzawa Y., Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr. Opin. Lipidol. 2003, 14:561-566.
28. Patel L., Buckels A.C., Kinghorn I.J., Murdock P.R., Holbrook J.D., Plumpton C., Macphee C.H., Smith S.A. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem. Biophys. Res. Commun. 2003, 300:472-476.
29. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
30. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
31. Satoh H., Nguyen M.T., Miles P.D., Imamura T., Usui I., Olefsky J.M. Adenovirus-mediated chronic " hyper-resistinemia" leads to in vivo insulin resistance in normal rats. J. Clin. Invest. 2004, 114:224-231.
32. Satoh H., Nguyen M.T., Trujillo M., Imamura T., Usui I., Scherer P.E., Olefsky J.M. Adenovirus-mediated adiponectin expression augments skeletal muscle insulin sensitivity in male Wistar rats. Diabetes 2005, 54:1304-1313.
33. Satoh H., Togo M., Hara M., Miyata T., Han K., Maekawa H., Ohno M., Hashimoto Y., Kurokawa K., Watanabe T. Advanced glycation endproducts stimulate mitogen-activated protein kinase and proliferation in rabbit vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 1997, 239:111-115.
34. Scherer P.E. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006, 55:1537-1545.
35. Scherer P.E., Williams S., Fogliano M., Baldini G., Lodish H.F. A novel serum protein similar to C1q produced exclusively in adipocytes. J. Biol. Chem. 1995, 270:26746-26749. 10.1074/jbc.270.45.26746.
36. Shanin S.N., Rybakina E.G., Novikova N.N., Kozinets I.A., Rogers V.J., Korneva E.A. Natural killer cell cytotoxic activity and c-Fos protein synthesis in rat hypothalamic cells after painful electric stimulation of the hind limbs and EHF irradiation of the skin. Med. Sci. Monit. 2005, 11:BR309-BR315.
37. Shetty G.K., Economides P.A., Horton E.S., Mantzoros C.S., Veves A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 2004, 27:2450-2457.
38. Slingerland J., Pagano M. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J. Cell Physiol. 2000, 183:10-17.
39. Song H., Xu Y. Gain of function of p53 cancer mutants in disrupting critical DNA damage response pathways. Cell Cycle 2007, 6:1570-1573.
40. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., Patel H.R., Ahima R.S., Lazar M.A. The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312.
41. Sylvester A.M., Chen D., Krasinski K., Andres V. Role of c-fos and E2F in the induction of cyclin: A transcription and vascular smooth muscle cell proliferation. J. Clin. Invest. 1998, 101:940-948.
42. Wang P., Xu T.Y., Guan Y.F., Su D.F., Fan G.R., Miao C.Y. Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide. Cardiovasc. Res. 2009, 81:370-380.
43. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., Yamashita S., Noda M., Kita S., Ueki K., Eto K., Akanuma Y., Froguel P., Foufelle F., Ferre P., Carling D., Kimura S., Nagai R., Kahn B.B., Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 2002, 8:1288-1295.
44. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., Mori Y., Ide T., Murakami K., Tsuboyama-Kasaoka N., Ezaki O., Akanuma Y., Gavrilova O., Vinson C., Reitman M.L., Kagechika H., Shudo K., Yoda M., Nakano Y., Tobe K., Nagai R., Kimura S., Tomita M., Froguel P., Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 2001, 7:941-946.
45. Yonemitsu Y., Kaneda Y., Tanaka S., Nakashima Y., Komori K., Sugimachi K., Sueishi K. Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo. Circ. Res. 1998, 82:147-156.